Pembrolizumab,Trastuzumab,Zolbetuximab,Nivolumab,Ipilimumab,Tislelizumab
Merck,Roche,astellas,BMS,Beigene,leap therapeutics
[]
...and don't forget the big one, pivotal zolbetuximab data from $alpmy in claudin18.2-positive patients, coming at 1:30pm #gi23 late-breaker
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.